Low risk to public health in the EU from low pathogenic avian influenza A(H7N7) viruses
ECDC assesses the epidemiological and virological information about human infections with low pathogenic avian influenza A(H7N7) viruses, in response to an outbreak on a poultry farm in the United Kingdom in February 2015.
On 2 February 2015, British authorities reported an outbreak of low pathogenic avian influenza virus A(H7N7) on a chicken farm in Hampshire in the United Kingdom. Culling of the birds in the affected holding has started, with restriction and surveillance zones established, and investigations into how the birds became infected have been initiated.
Three persons who had been exposed to the flock reported an influenza-like illness or conjunctivitis, however no human infections with A(H7N7) or other respiratory viruses were identified.
Groups at risk for infection include people with occupational exposure to infected poultry, e.g. during the culling and destruction process when there are outbreaks on poultry farms. However, the risk for zoonotic transmission to the general public in EU/EEA countries is considered to be extremely low.
Outbreaks in poultry holdings caused by low pathogenic avian influenza A(H7N7) viruses have been reported previously in Europe, causing infections in humans occupationally exposed to infected poultry . Such infections caused mild disease with influenza-like symptoms or conjunctivitis.
Rapid Risk Assessment: Human infection by low pathogenic avian influenza A(H7) viruses, 13 February 2015
13 Feb 2015 - This rapid risk assessment summarises the epidemiological and virological information about human infections with low pathogenic avian influenza A(H7N7) viruses and assesses the risk to public health in the EU/EEA, in response to this outbreak.
2019 Seasonal influenza assessment: currently dominating viruses point at possible heavy impact on the elderly and healthcare systems
18 Dec 2019 - The first virus detections for the 2019/2020 season indicate co-circulation of influenza types A (71%) and B (29%) viruses in the WHO European Region. This is a mix which potentially could result in high mortality in elderly patients and a heavy burden on healthcare services, warns the European Centre for Disease Control and Prevention (ECDC) and World Health Organization (WHO) Regional Office for Europe in a joint assessment issued today.
World Health Organization recommendations for the influenza virus vaccine composition for the 2020 southern hemisphere season
11 Oct 2019 - On September 2019, WHO has agreed on the recommended composition of the quadrivalent and trivalent influenza vaccines for the southern hemisphere 2020 influenza season.
WHO recommendations for influenza virus vaccine composition for the 2019–2020 northern hemisphere season
1 Mar 2019 - On 18–20 February 2019, the World Health Organization (WHO) agreed on the recommended composition of the quadrivalent influenza vaccine for the northern hemisphere 2019–2020 influenza season: an A/Brisbane/02/2018 (H1N1)pdm09-like virus, an A(H3N2) virus component to be announced on 21 March 2019, a B/Colorado/06/2017-like virus (B/Victoria/2/87 lineage) and a B/Phuket/3073/2013-like virus (B/Yamagata/16/88 lineage).